Comparing Leuprolide vs Relugolix
| Leuprolide | Relugolix |
|
|---|
| Leuprolide | Relugolix |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Prostate Cancer, Endometriosis, Uterine Fibroids, Breast Cancer - Adjuvant, Precocious Puberty, Female Infertility, Hirsutism, Uterine Leiomyomata. Leuprolide may also be used for... View more |
Prescription only
Prescribed for Prostate Cancer. Relugolix may also be used for purposes not listed in this medication guide. |
Related suggestions Prostate Cancer
Popular comparisons
|
|||||||
| More about Leuprolide | More about Relugolix | ||||||||
| Ratings & Reviews | |||||||||
|
Leuprolide has an average rating of 5.6 out of 10 from a total of 404 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 34% reported a negative effect. |
Relugolix has an average rating of 7.7 out of 10 from a total of 24 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Leuprolide side effects |
View all Relugolix side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Leuprolide prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Camcevi, Eligard, Fensolvi, Lupron, Lupron Depot, Lupron Depot-PED, Lutrate Depot | Orgovyx | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
4.25 hours |
60.8 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 282 drugs are known to interact with Leuprolide:
|
A total of 362 drugs are known to interact with Relugolix:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
January 26, 1989 |
December 18, 2020 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.